首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1597320

药物测试市场 - 全球产业规模、份额、趋势、机会和预测，按产品、样品、药物类型、最终用户、地区和竞争细分，2019-2029F

Drug Testing Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Sample, By Drug Type, By End User, By Region, & Competition, 2019-2029F

出版日期: 2024年11月25日 | 出版商:

TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年全球药物测试市场估值为138.5 亿美元，预计在预测期内将出现令人印象深刻的增长，到2029 年复合年增长率为5.05%。药物测试市场正在强劲扩张。非法药物使用发生率的上升刺激了各部门的需求，特别是在工作场所、执法机构和医疗机构。大麻在北美等主要市场不断扩大合法化，进一步扩大了药物检测服务的范围。

市场概况
预测期	2025-2029
2023 年市场规模	138.5亿美元
2029 年市场规模	186.6亿美元
2024-2029 年复合年增长率	5.05%
成长最快的细分市场	尿液样本
最大的市场	北美洲

COVID-19 大流行加剧了对药物检测的需求，这主要是由于劳动力中心理健康问题和压力引起的药物消费激增，使得工作场所药物检测比以往任何时候都更加重要。因此，组织越来越多地采用药物测试方案来更有效地管理药物滥用。由于各行业对药物滥用管理的持续需求以及测试解决方案的持续创新，该市场仍有望实现显着增长。然而，区域监管的不一致和消费者不断变化的需求将继续影响市场的发展轨迹，可能带来挑战和机会。

主要市场驱动因素

药物滥用和非法药物使用增加

严格的政府法规和法律

药物测试的技术进步

主要市场挑战

不同地区的监理差异

隐私和道德问题

先进测试技术的成本和可近性

主要市场趋势

人工智慧 (AI) 和机器学习在药物测试中的集成

扩大对非侵入性检测方法的关注

大麻专用测试解决方案的需求增加

细分市场洞察

范例见解

区域洞察

Global Drug Testing Market was valued at USD 13.85 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.05% through 2029. The global drug testing market is experiencing robust expansion, driven by growing concerns surrounding substance abuse, the enforcement of stricter regulations, and the continuous development of advanced testing technologies. Rising incidences of illicit drug use are fueling demand across sectors, particularly in workplaces, law enforcement agencies, and healthcare facilities. The expanding legalization of cannabis in key markets, such as North America, is further broadening the scope for drug testing services.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 13.85 Billion
Market Size 2029	USD 18.66 Billion
CAGR 2024-2029	5.05%
Fastest Growing Segment	Urine Samples
Largest Market	North America

The COVID-19 pandemic has intensified the need for drug testing, primarily due to the surge in mental health issues and stress-induced drug consumption within the workforce, making workplace drug testing more critical than ever. As a result, organizations are increasingly adopting drug testing protocols to manage substance abuse more effectively. The market remains poised for significant growth, driven by a sustained need for drug abuse management across industries and ongoing innovations in testing solutions. However, regional regulatory inconsistencies and the evolving demands of consumers will continue to influence the market's trajectory, potentially creating both challenges and opportunities.

Key Market Drivers

Increasing Substance Abuse and Illicit Drug Use

The escalating rates of substance abuse and illicit drug use globally are major catalysts driving the growth of the drug testing market. As drug misuse becomes more pervasive, there is an increasing need for monitoring mechanisms, creating heightened demand for drug testing services across various sectors. With substance abuse affecting employee performance, safety, and productivity, many businesses, especially in high-risk sectors like transportation, healthcare, and construction, have been mandated or encouraged to implement drug testing policies. Employers are investing in pre-employment screening, random drug tests, and post-accident testing to maintain a safe work environment and mitigate risks associated with impaired employees. This has significantly expanded the demand for both in-house and outsourced drug testing solutions. As illicit drug use continues to rise, governments and regulatory bodies worldwide are instituting stricter laws to combat drug misuse, especially in the workplace and public sectors. Many countries have legislated mandatory drug testing for employees in specific industries, leading to increased adoption of testing solutions. For example, in the U.S., laws such as the Drug-Free Workplace Act require companies to conduct drug testing to maintain eligibility for federal funding. The growing legal pressure surrounding drug use across different regions is fueling the adoption of testing services.

As illicit drug use contributes to a range of health issues, healthcare facilities, rehabilitation centers, and treatment programs are increasingly utilizing drug testing to monitor patients. For instance, drug testing is vital in pain management clinics, addiction treatment centers, and hospitals to ensure that patients are adhering to prescribed medications and not engaging in drug misuse. The surge in demand for rehabilitation services, driven by higher rates of substance abuse, is contributing to the expansion of the drug testing market. The rising incidence of drug-related offenses and impaired driving has led law enforcement agencies to intensify drug testing, particularly in road safety initiatives. Random roadside testing for drugs is becoming more common, especially in regions with high rates of driving under the influence of illicit substances. The focus on reducing drug-related traffic incidents is prompting governments to invest in more advanced drug testing technologies and methodologies, further boosting market growth. The global increase in mental health issues, such as stress, depression, and anxiety, has contributed to a rise in self-medication through illicit drug use. This social shift is driving a growing need for drug testing not only in workplaces but also in educational settings and public safety programs. Schools, universities, and community programs are incorporating drug testing as a preventive measure to identify at-risk individuals and curb the spread of substance abuse among young adults.

Stringent Government Regulations and Laws

Stringent government regulations and laws play a pivotal role in driving the growth of the global drug testing market by creating a legal framework that necessitates the use of drug testing across various sectors, from the workplace to law enforcement and healthcare. These regulations are designed to mitigate the risks associated with drug abuse and ensure public safety, thus fueling demand for comprehensive drug testing solutions. Governments around the world have implemented laws that require drug testing in certain high-risk industries such as transportation, healthcare, and manufacturing. In the United States, for example, the Drug-Free Workplace Act mandates federal contractors and grantees to maintain drug-free workplaces, which involves regular drug testing of employees. Similar regulations exist in many European and Asian countries, creating a substantial market for drug testing services in these regions. The legal obligation for pre-employment, random, and post-accident drug testing is expanding the scope of the drug testing market.

Stringent laws regarding impaired driving and drug-related offenses are prompting governments to invest in drug testing technologies, particularly for law enforcement. Roadside drug testing is becoming more widespread in response to growing concerns over drug-impaired driving. Regulations in countries like the U.S., Canada, and many European nations mandate random and targeted testing for drivers to curb road accidents related to drug use. Additionally, as laws tighten around the consumption of controlled substances, such as cannabis in certain regions, there is an increasing demand for specialized testing kits that can detect drug use in a variety of contexts. Governments are also tightening regulations in healthcare settings to ensure patients are adhering to prescribed medications and not abusing illicit substances. The increasing number of government mandates around controlled substance use has pushed healthcare providers and rehabilitation centers to incorporate drug testing as part of routine patient monitoring. This is particularly evident in addiction treatment facilities, where regulations require regular drug screening for patients undergoing rehabilitation programs. As governments continue to impose stricter controls on prescription drugs and manage the opioid crisis, drug testing in healthcare is becoming a more regulated activity, further driving the market.

The legalization of cannabis in various U.S. states and other countries is another significant factor pushing the demand for drug testing solutions. While legalization allows for regulated use of cannabis, it also brings about the need for testing to prevent misuse, particularly in the workplace and on the road. New regulations have emerged to specifically address cannabis use, requiring employers and law enforcement agencies to adopt specialized drug testing kits capable of detecting THC levels. This has further expanded the need for drug testing services and technologies tailored to detect cannabis consumption. International regulations such as those from the International Labour Organization (ILO) and the World Health Organization (WHO) are also influencing national policies, leading governments to tighten drug testing laws in certain sectors. This harmonization of global standards is compelling multinational companies and government agencies to adopt drug testing policies that comply with both local and international regulations. The growing focus on global compliance for workplace safety and public health further supports market expansion. Stringent government regulations and laws are essential drivers of growth for the global drug testing market. These regulations not only ensure safety and compliance across workplaces and public safety sectors but also fuel the demand for advanced and accurate drug testing technologies. The evolving legal landscape surrounding drug use and its impact on public health, safety, and productivity continues to drive innovation and market expansion in the drug testing industry.

Technological Advancements in Drug Testing

Technological advancements in drug testing are playing a crucial role in driving the growth of the global drug testing market by increasing the accuracy, speed, and accessibility of testing solutions. These innovations not only enhance the reliability of results but also broaden the application of drug testing across various industries, significantly expanding market opportunities. One of the most significant advancements in drug testing is the development of rapid testing devices. These portable and easy-to-use devices provide immediate results, making them particularly valuable for workplace screenings, roadside testing, and emergency situations. The ability to conduct on-the-spot testing with minimal sample collection reduces wait times, enhances operational efficiency, and ensures timely decision-making. Rapid testing solutions, such as oral fluid tests and urine dipsticks, have gained popularity due to their convenience and cost-effectiveness, driving widespread adoption across sectors such as law enforcement, healthcare, and employment.

Advancements in analytical techniques, such as mass spectrometry and liquid chromatography, have significantly improved the precision and accuracy of drug testing. These technologies enable the detection of a broader range of substances at lower concentrations, offering more reliable results. High-throughput screening methods, for instance, allow for the simultaneous analysis of multiple drug samples in a single run, reducing processing time and increasing testing capacity. The enhanced accuracy of these methods is critical in sectors where false positives or negatives could have serious consequences, such as in medical diagnostics, law enforcement, and workplace safety. Emerging technologies such as biometric authentication and wearable devices are driving innovation in drug testing. Wearables capable of monitoring physiological indicators, such as sweat or heart rate variability, are being developed to detect substance abuse in real time. For example, wearable patches that monitor alcohol consumption or drug use through sweat are gaining traction in clinical and rehabilitation settings. Additionally, biometric identification methods, including fingerprint analysis, are being integrated into drug testing systems to ensure secure and tamper-proof sample collection, further bolstering the accuracy and credibility of results. Non-invasive testing methods are another area where technological progress is significantly impacting the drug testing market. Traditional urine and blood tests can be perceived as intrusive, leading to reluctance in certain settings. However, non-invasive alternatives, such as saliva or hair follicle testing, are gaining acceptance due to their ease of collection and reduced invasiveness. These methods are particularly advantageous in workplace settings, where employees may resist invasive procedures. Moreover, the development of oral fluid testing kits, which offer both convenience and reliability, is expanding the scope of drug testing in law enforcement, schools, and hospitals.

The integration of artificial intelligence (AI) and automation in drug testing laboratories is streamlining testing processes and improving operational efficiency. AI algorithms are being employed to analyze drug test results, reduce human error, and identify patterns in drug abuse. Automation is enhancing lab workflows by automating sample preparation, analysis, and result reporting, enabling laboratories to handle higher volumes of tests while maintaining consistency and accuracy. These innovations are particularly beneficial in high-demand environments, such as forensic testing and large-scale drug testing in medical facilities. As cannabis legalization expands globally, there is an increasing demand for specialized testing solutions that can detect cannabis use accurately. Technological advancements have led to the development of highly sensitive testing kits that can measure THC levels in the blood, saliva, and urine, allowing for the monitoring of cannabis consumption in both workplace and law enforcement settings. The growing need for such testing solutions has opened up new market segments, particularly in regions with expanding cannabis legalization. Technological advancements are reshaping the global drug testing market by improving testing efficiency, accuracy, and accessibility. From rapid testing devices to AI-driven laboratory automation, these innovations are driving the adoption of drug testing across various sectors, including healthcare, law enforcement, and the workplace. As technology continues to evolve, the market is expected to see further expansion, offering enhanced solutions for the detection and management of substance abuse.

Key Market Challenges

Regulatory Variations Across Regions

One of the primary challenges restricting the growth of the global drug testing market is the inconsistency of regulatory frameworks across different regions. While countries like the United States and Canada have robust regulations in place, the legal landscape for drug testing remains fragmented globally. In some countries, drug testing in the workplace and in public settings is either not mandatory or subject to limited legal oversight. Furthermore, regulations on substances such as cannabis are evolving rapidly, leading to uncertainty in legal compliance and testing protocols.

This inconsistency in regulations can create significant barriers for multinational companies that need to implement standardized drug testing policies across various regions. In addition, changes in laws or the introduction of new regulations can lead to unexpected shifts in demand for specific testing solutions, making it difficult for market participants to plan long-term strategies effectively.

Privacy and Ethical Concerns

Privacy concerns surrounding drug testing remain a significant hurdle, particularly in workplace and educational settings. The collection and analysis of personal biological samples, such as urine, saliva, or hair, can raise ethical questions regarding the invasion of privacy and the potential for discrimination based on test results. There are also concerns related to consent, as individuals may feel pressured into participating in drug testing programs, especially when such testing is mandatory for employment or safety reasons.

Ethical concerns can extend to the accuracy of testing methods. False positives or negatives in drug testing can lead to serious consequences, such as wrongful termination, legal disputes, or incorrect medical diagnoses. These issues can lead to resistance from employees, students, and even patients who may perceive drug testing as an infringement on their rights or a breach of confidentiality.

Cost and Accessibility of Advanced Testing Technologies

The adoption of cutting-edge drug testing technologies, such as mass spectrometry or advanced chromatographic methods, can be cost-prohibitive for smaller businesses, healthcare providers, and law enforcement agencies, particularly in developing economies. High equipment costs, maintenance expenses, and the need for skilled personnel to operate sophisticated testing systems limit the widespread adoption of these technologies in certain regions or sectors.

While rapid testing devices have made testing more accessible, they may not always offer the same level of accuracy or comprehensive detection capabilities as laboratory-based methods. This creates a trade-off between affordability and precision, with many organizations opting for less expensive, albeit less accurate, testing solutions. This discrepancy in the availability and affordability of advanced testing methods can hinder the growth of the market in lower-income regions and industries with tight budget constraints.

Key Market Trends

Integration of Artificial Intelligence (AI) and Machine Learning in Drug Testing

The integration of AI and machine learning (ML) technologies is one of the most transformative trends in the drug testing market. AI algorithms are being increasingly employed to analyze and interpret drug test results with greater accuracy and efficiency. These technologies can enhance the detection capabilities of drug testing systems, enabling the identification of a broader range of substances, even in trace amounts.

AI is also streamlining the entire testing process, from sample collection to result interpretation, making the process faster and less prone to human error. Machine learning can be used to predict trends in substance abuse patterns, thereby enabling proactive interventions. As these technologies become more cost-effective, their adoption is expected to rise across various sectors, particularly in law enforcement and healthcare, where precision and speed are paramount.

Expanding Focus on Non-Invasive Testing Methods

Another critical trend is the increasing demand for non-invasive drug testing methods. Traditional drug testing procedures, such as urine and blood testing, can be seen as intrusive and often face resistance from employees, patients, and students. Non-invasive alternatives like saliva, sweat, and hair follicle testing are gaining traction due to their ease of collection, less discomfort, and ability to detect drug use over longer periods.

Saliva-based testing, for example, is already being utilized in workplace environments and law enforcement, particularly for roadside drug testing, because it is quick, efficient, and can provide immediate results. As these methods become more advanced and offer enhanced detection capabilities, they are expected to drive broader adoption across multiple sectors, making drug testing more accessible and less invasive for users. This shift is likely to play a significant role in encouraging widespread acceptance and participation in drug testing programs.

Rise in Demand for Cannabis-Specific Testing Solutions

The growing legalization of cannabis in various countries, including several states in the U.S., Canada, and parts of Europe, is driving a surge in demand for cannabis-specific drug testing solutions. As cannabis use becomes more mainstream, both in medical and recreational contexts, there is an increasing need for testing solutions that can specifically detect the active compounds in cannabis, such as THC (tetrahydrocannabinol), in various biological samples.

Employers, law enforcement agencies, and healthcare providers are seeking accurate and reliable testing methods to detect cannabis use, whether for workplace safety or public safety. This trend is creating opportunities for innovation in cannabis-specific testing technologies, such as saliva and breath tests, that can detect impairment levels rather than just the presence of the drug. As cannabis regulations continue to evolve, testing solutions that can accurately differentiate between legal use and impairment will be critical to the future growth of the market.

Segmental Insights

Sample Insights

Based on the category of Sample, the Urine Sample segment emerged as the dominant in the global market for Drug Testing in 2023. Urine testing is among the most affordable options in the drug testing market. It requires relatively low operational costs, including cheaper equipment and reagent costs compared to more complex tests like blood or hair follicle testing. Furthermore, urine tests are quick to administer, offering a fast turnaround time for results. This efficiency makes urine testing highly attractive for companies and institutions that need to conduct frequent screenings, such as in large workplaces or public safety programs. For large-scale testing, such as in sports organizations, the World Anti-Doping Agency (WADA), and federal drug screenings, the ability to conduct large volumes of tests affordably is a significant advantage. The convenience and low cost of urine testing make it an ongoing staple for these sectors. Urine testing can detect a wide array of substances, including illicit drugs, prescription medications, and alcohol metabolites. The detection window for urine samples is typically between 1 to 3 days for most drugs but can extend up to a week or longer depending on the substance and the individual's metabolism. This range of detection makes urine tests versatile, allowing for both routine and random testing in various settings, from the workplace to clinical and forensic environments. Moreover, urine tests can detect a range of drugs, such as cannabinoids, opiates, cocaine, amphetamines, and benzodiazepines, making it a reliable choice for comprehensive substance monitoring in industries with strict safety and compliance requirements.

Urine sample collection is straightforward, minimally invasive, and widely accepted by participants, which helps avoid the issues related to privacy and consent often seen with blood testing. Although there are potential concerns about tampering or adulteration, the drug testing industry has developed sophisticated methods to ensure sample integrity, such as observing collection procedures, using adulteration detection kits, and employing chain-of-custody protocols. In comparison, more invasive or complex methods like hair or blood testing may be perceived as more intrusive, leading to resistance or logistical challenges in certain settings, particularly in large-scale or routine screenings. Technological innovations in urine drug testing have enhanced the sensitivity and specificity of test results. For example, advancements in immunoassay and chromatography techniques have enabled more accurate detection of low levels of drugs in urine samples. This has bolstered the credibility and reliability of urine testing as a diagnostic tool across various sectors. Moreover, the development of rapid urine tests that provide results within minutes has made it even more attractive for point-of-care testing, especially in environments like emergency departments, sports events, or roadside drug testing. These factors collectively contribute to the growth of this segment.

Regional Insights

North America emerged as the dominant in the global Drug Testing market in 2023, holding the largest market share in terms of value. North America, especially the United States, has established some of the most comprehensive and stringent regulatory frameworks around drug testing, particularly in the workplace, healthcare, and law enforcement sectors. Laws such as the Drug-Free Workplace Act and regulations from the Department of Transportation (DOT) mandate drug testing for employees in certain industries, particularly those involved in safety-sensitive roles such as transportation, aviation, and healthcare. The Workplace Drug Testing policy in the U.S. requires regular drug screening of employees to ensure safety and compliance, driving substantial demand for drug testing solutions. Additionally, regulations governing drug testing in law enforcement, such as roadside testing for impaired driving, are becoming stricter, further increasing the demand for drug testing kits and technologies. These legal mandates ensure that drug testing remains a critical part of safety protocols across various sectors in North America, reinforcing the region's dominant position in the global market. North America has a significantly high rate of substance abuse, particularly in the United States, where opioid abuse, as well as the increasing use of marijuana following legalization in several states, are major concerns. The growing opioid crisis has led to an increased emphasis on drug testing in medical and rehabilitation settings, where drug abuse monitoring is critical. As a result, there is heightened demand for drug testing services and technologies to monitor patients, manage addiction, and ensure that medications are being used correctly. Moreover, the increasing legalization of cannabis in several U.S. states has spurred the need for specialized cannabis testing, contributing further to the expansion of the drug testing market. North America's market dominance is partly driven by this specific demand for cannabis-specific tests, such as those detecting THC levels in urine, saliva, or blood.

Key Market Players

Quest Diagnostics Incorporated
Abbott
F. Hoffmann-La Roche Ltd.
QuidelOrtho Corporation
Thermo Fisher Scientific, Inc.
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc
Laboratory Corporation of America Holdings
Clinical Reference Laboratory, Inc

Report Scope:

In this report, the Global Drug Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Drug Testing Market, By Product:

Consumables
Instruments
Rapid Testing Devices
Services

Drug Testing Market, By Sample:

Urine Samples
Oral Fluid Samples
Hair Samples
Other

Drug Testing Market, By Drug Type:

Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Others

Drug Testing Market, By End User:

Drug Testing Laboratories
Workplaces
Hospitals
Others

Drug Testing Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Drug Testing Market.

Available Customizations:

Global Drug Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Drug Testing Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Consumables, Instruments, Rapid Testing Devices, Services)
- 5.2.2. By Sample (Urine Samples, Oral Fluid Samples, Hair Samples, Other)
- 5.2.3. By Drug Type (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Others)
- 5.2.4. By End User (Drug Testing Laboratories, Workplaces, Hospitals, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2023)
5.3. Market Map

6. North America Drug Testing Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Sample
- 6.2.3. By Drug Type
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Drug Testing Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Sample
    - 6.3.1.2.3. By Drug Type
    - 6.3.1.2.4. By End User
- 6.3.2. Canada Drug Testing Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Sample
    - 6.3.2.2.3. By Drug Type
    - 6.3.2.2.4. By End User
- 6.3.3. Mexico Drug Testing Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Sample
    - 6.3.3.2.3. By Drug Type
    - 6.3.3.2.4. By End User

7. Europe Drug Testing Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Sample
- 7.2.3. By Drug Type
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Drug Testing Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Sample
    - 7.3.1.2.3. By Drug Type
    - 7.3.1.2.4. By End User
- 7.3.2. United Kingdom Drug Testing Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Sample
    - 7.3.2.2.3. By Drug Type
    - 7.3.2.2.4. By End User
- 7.3.3. Italy Drug Testing Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Sample
    - 7.3.3.2.3. By Drug
    - 7.3.3.2.4. By End User
- 7.3.4. France Drug Testing Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Sample
    - 7.3.4.2.3. By Drug Type
    - 7.3.4.2.4. By End User
- 7.3.5. Spain Drug Testing Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Sample
    - 7.3.5.2.3. By Drug Type
    - 7.3.5.2.4. By End User

8. Asia-Pacific Drug Testing Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Sample
- 8.2.3. By Drug Type
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Drug Testing Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Sample
    - 8.3.1.2.3. By Drug Type
    - 8.3.1.2.4. By End User
- 8.3.2. India Drug Testing Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Sample
    - 8.3.2.2.3. By Drug Type
    - 8.3.2.2.4. By End User
- 8.3.3. Japan Drug Testing Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Sample
    - 8.3.3.2.3. By Drug Type
    - 8.3.3.2.4. By End User
- 8.3.4. South Korea Drug Testing Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Sample
    - 8.3.4.2.3. By Drug Type
    - 8.3.4.2.4. By End User
- 8.3.5. Australia Drug Testing Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Sample
    - 8.3.5.2.3. By Drug Type
    - 8.3.5.2.4. By End User

9. South America Drug Testing Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Sample
- 9.2.3. By Drug Type
- 9.2.4. By End User
- 9.2.5. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Drug Testing Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Sample
    - 9.3.1.2.3. By Drug Type
    - 9.3.1.2.4. By End User
- 9.3.2. Argentina Drug Testing Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Sample
    - 9.3.2.2.3. By Drug Type
    - 9.3.2.2.4. By End User
- 9.3.3. Colombia Drug Testing Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Sample
    - 9.3.3.2.3. By Drug Type
    - 9.3.3.2.4. By End User

10. Middle East and Africa Drug Testing Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Sample
- 10.2.3. By Drug
- 10.2.4. By End User
- 10.2.5. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Drug Testing Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Procedure
    - 10.3.1.2.3. By End User
- 10.3.2. Saudi Arabia Drug Testing Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Sample
    - 10.3.2.2.3. By Drug
    - 10.3.2.2.4. By End User
- 10.3.3. UAE Drug Testing Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Sample
    - 10.3.3.2.3. By Drug
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Drug Testing Market: SWOT Analysis

14. Competitive Landscape

14.1. Quest Diagnostics Incorporated
- 14.1.1. Business Overview
- 14.1.2. Product & Service Offerings
- 14.1.3. Recent Developments
- 14.1.4. Financials (If Listed)
- 14.1.5. Key Personnel
- 14.1.6. SWOT Analysis
14.2. Abbott
14.3. F. Hoffmann-La Roche Ltd.
14.4. QuidelOrtho Corporation
14.5. Thermo Fisher Scientific, Inc.
14.6. Siemens Healthineers AG
14.7. Bio-Rad Laboratories, Inc.
14.8. Agilent Technologies, Inc
14.9. Laboratory Corporation of America Holdings
14.10.Clinical Reference Laboratory, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

02-2729-4219

+886-2-2729-4219

License/价格

药物测试市场 - 全球产业规模、份额、趋势、机会和预测，按产品、样品、药物类型、最终用户、地区和竞争细分，2019-2029F

Drug Testing Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Sample, By Drug Type, By End User, By Region, & Competition, 2019-2029F

主要市场驱动因素

主要市场挑战

主要市场趋势

细分市场洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：药物检测市场展望

第 6 章：北美药物检测市场展望

第 7 章：欧洲药物检测市场展望

第 8 章：亚太地区药物检测市场展望

第 9 章：南美洲药物检测市场展望

第10章：中东和非洲药物检测市场展望

第 11 章：市场动态

第 12 章：市场趋势与发展

第 13 章：全球药物检测市场：SWOT 分析

第14章：竞争格局

第 15 章：策略建议

第16章调查会社について・免责事项

Key Market Players

Report Scope:

Drug Testing Market, By Product:

Drug Testing Market, By Sample:

Drug Testing Market, By Drug Type:

Drug Testing Market, By End User:

Drug Testing Market, By Region:

Competitive Landscape

Available Customizations:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Drug Testing Market Outlook

6. North America Drug Testing Market Outlook

7. Europe Drug Testing Market Outlook

8. Asia-Pacific Drug Testing Market Outlook

9. South America Drug Testing Market Outlook

10. Middle East and Africa Drug Testing Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Drug Testing Market: SWOT Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer